Accès à distance ? S'identifier sur le proxy UCLouvain
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission : the COMET trial.
Primary tabs
| Document type | Article de périodique (Journal article) – Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't |
|---|---|
| Publication date | 2010 |
| Language | Anglais |
| Journal information | "Annals of the Rheumatic Diseases" - Vol. 69, no. 1, p. 222-5 (2010) |
| Peer reviewed | yes |
| Publisher | B M J Group ((United Kingdom) London) |
| issn | 0003-4967 |
| e-issn | 1468-2060 |
| Affiliations |
UCL
- (SLuc) Service de rhumatologie UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales |
| MESH Subject | Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Receptors, Tumor Necrosis Factor - therapeutic use ; Remission Induction ; Severity of Illness Index ; Treatment Outcome ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Immunoglobulin G - therapeutic use ; Male ; Methotrexate - therapeutic use ; Middle Aged |
| Links |
| Bibliographic reference | Kekow, J ; Moots, R J ; Emery, P ; Durez, Patrick ; Koenig, A ; et. al. Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission : the COMET trial.. In: Annals of the Rheumatic Diseases, Vol. 69, no. 1, p. 222-5 (2010) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/105735 |